Presentation TCT 2013 Left Main Disease with an Occluded RCA: Implications for Revascularization Decision-making Presenter: Alaide Chieffo October 28, 2013
Presentation TCT 2013 Everolimus-eluting Stents in Left Main Disease: Precombat II 3 Year Results Presenter: Young-Hak Kim October 28, 2013
Presentation TCT 2013 The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated With The Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and Paclitaxel-Eluting... Presenter: Aris Moschovitis, Giulio Stefanini, Michael Magro, Lorenz R?ber, Bindu Kalesan, Masanori Taniwaki, Joost Daemen, Peter Wenaweser, Ron Van Domburg, Bernhard Meier, Peter Juni, Patrick Serruys, Stephan Windecker January 31, 2013
Presentation TCT 2013 Comparison of Clopidogrel and Prasugrel in Patients with Unprotected Left main Disease Treated with Everolimus-Eluting Stents: Insight From the Florence Left Main-PCI Registry Presenter: Renato Valenti, Angela Migliorini, Guido Parodi, Ruben Vergara, Nazario Carrabba, Emilio Vincenzo Dovellini, David Antoniucci January 31, 2013
Presentation TCT 2012 Diabetes Mellitus, Multivessel, and Left Main Disease: Not So Fast, PCI for Many! Presenter: Kevin Beatt October 26, 2012
Presentation TCT 2012 Diabetes Mellitus, Multivessel, and Left Main Disease: CABG for All! Presenter: Joseph Sabik October 26, 2012
Presentation TCT 2012 Cases 5 and 6: FFR in Left Main Disease: From Simple Ostial to Complex Presenter: Soo-Jin Kang October 25, 2012
Presentation TCT 2012 When Is PCI Justified in Complex (Non-Left Main) Multivessel Disease with Current Drug-Eluting Stents? Presenter: Dean Kereiakes October 25, 2012
Presentation TCT 2012 FFR Decision-Making in a Patient with Left Main Disease and Atrial Septal Defect Presenter: Naoto Inoue October 25, 2012
Presentation TCT 2012 Patient with STEMI, Proximal LAD Occlusion, and Complex Left Main/Multivessel Disease: How to Treat? Presenter: Jacek Legutko October 24, 2012
Presentation TCT 2012 ISAR-LEFT MAIN 2: A Prospective, Randomized Trial of Everolimus-Eluting vs. Zotarolimus-Eluting Stents in Patients with Unprotected Left Main Disease Presenter: Julinda Mehilli October 24, 2012
News Conference News TCT 2012 PEACE: Data Demonstrate Benefits of Plaque Identification in High-Risk Patients October 24, 2012
News Conference News TCT 2012 ISAR-LEFT MAIN 2: Second-Generation DES Effective in Left Main CAD October 24, 2012
Presentation TCT 2012 TCT-66. Impact of Residual Chronic Total Occlusion of Right Coronary Artery on the Long Term Outcome in Patients Treated for Unprotected Left Main Disease: The MIlan and... Presenter: Kensuke Takagi October 23, 2012
Presentation TCT 2012 TCT-51. Comparison of Clopidogrel and Prasugrel in Patients with Unprotected Left main Disease Treated with Everolimus-eluting Stents: Insight from the Florence Left Main-PCI... Presenter: Renato Valenti October 23, 2012
Presentation TCT 2012 TCT-41. The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated with the Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and... Presenter: Giulio Stefanini October 23, 2012
Presentation TCT 2012 TCT-42. Long-term Safety and Efficacy of Percutaneous Coronary Intervention with Stenting and Coronary Artery Bypass Surgery for Left Main Disease: Final Five-year Follow-up... Presenter: Patrick Serruys October 23, 2012
Presentation TCT 2012 Multivessel Disease and Left Main Intervention: Indications and Outcomes Presenter: David Holmes Jr October 23, 2012